Cargando…
Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer
Oral mucositis (OM) can be a significant problem for patients undergoing radiation or chemoradiation for head and neck cancer. In modern clinical trials, grade 3–4 OM can be seen in over 40% of patients and can cause a significant impact on their quality of life (QOL). Despite this fact, strategies...
Autores principales: | Judge, Lauren F., Farrugia, Mark K., Singh, Anurag K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184418/ https://www.ncbi.nlm.nih.gov/pubmed/34164550 http://dx.doi.org/10.21037/atm-20-3931 |
Ejemplares similares
-
Intravenous fluids for pain management in head and neck cancer patients undergoing chemoradiation
por: Rivers, Charlotte I., et al.
Publicado: (2021) -
Matched pair analysis for comparison of survival outcome of alternative regimens to standard three-weekly cisplatin-based concurrent chemoradiation of head and neck cancer
por: Han, Hye Ri, et al.
Publicado: (2021) -
Assessment of oral mucositis during concurrent chemoradiation of head and neck cancers using patient-reported measurement scale
por: Chaitanya, Nallan CSK, et al.
Publicado: (2018) -
Effect of vocal rehabilitation after chemoradiation for non-laryngeal head and neck cancers
por: Sreenivas, Athulya, et al.
Publicado: (2021) -
Editorial to the head and neck cancer—series
por: Seshadri, Mukund
Publicado: (2021)